Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Enzene Biosciences launches Cetuximab, biosimilar of cancer drug Erbitux
Cetuximab is a therapeutic chimeric monoclonal antibody that is used as a targeted therapy for metastatic colorectal cancer (mCRC)…
China poised to lead the way with world’s first oral insulin for type 2 diabetes: GlobalData
HTIT has recently submitted a marketing authorisation application in China for first oral insulin for type 2 diabetes
DPSRU hosts workshop on role of councils to facilitate implementation of NEP 2020
DPSRU to collate thoughts and perceptions for implementation of NEP 2020 at a larger national level conference
Pharmanovia pledges commitment to SBTI net zero target
Pilot transition from air freight to sea freight cut potential CO2 emissions by c.470,000 kg
Eisai to grant 625 mn yen to GHIT Fund for developing medicines for neglected tropical diseases,…
Eisai has participated in 23 joint research projects to develop new medicines and vaccines for mycetoma, malaria and filariasis,…
Neuralink, Elon Musk’s brain-implant company, announces US FDA approval for clinical trials
Musk envisions brain implants could cure a range of conditions including obesity, autism, depression and schizophrenia as well as…
For pharma cos, formulation exports to rise 7-9 per cent this fiscal
Revival in US sales, sustained healthy performance in rest of the world to drive growth
Parkinson’s unmet needs present significant opportunity for new entrants: GlobalData
The need for disease-modifying therapies is one of the highest unmet needs and if a curative or disease-modifying agent was…
Indegene, ConTIPI Medical partner to launch ProVate, a device to treat pelvic organ prolapse in…
The device has a 510(k) clearance from the FDA for marketing in the US and has been granted the CE mark for marketing in Europe
Eminence Business Media hosts sixth edition of Annual Pharma Project & Portfolio Management…
The programme comprised various discussion topics for project and portfolio management teams through interactive sessions and…